Product search
Filter
Search results
BIOPHEN Factor IX (2.5)
Assay proposed for the measurement of factor IX activity in research applications.
Factor XIIa, Human
Research studies or protocols where a source of highly purified human factor XIIa is required.
Protein Z, Human
ZYMUTEST HIA, IgGAM Screening
Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT. Clinical suspicion of HIT during heparin therapy.
ZYMUTEST vWF:CBA (Collagen Binding Assay)
Diagnosis of von Willebrand disease (vWD). Assay of vWF:CBA in clinical samples, as a disease marker or as an indicator for cardiovascular diseases.
Antithrombin & Heparin Cofactor II Deficient Plasma
For any in vitro protocol or research study where a source of human AT/HCII deficient plasma is required.
Heparin Cofactor II Deficient Plasma
For any in vitro protocol or research study where a source of human heparin cofactor II deficient plasma is required.
Factor II (Prothrombin), anti-human, mouse, IgG
ZYMUTEST HIA Mono-Strip, IgG
Individual test. Clinical suspicion of HIT during heparin therapy. Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA Mono Strip IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
ZYMUTEST HIA, IgG
Clinical suspicion of HIT during heparin therapy Clinical suspicion of vaccine-induced immune thrombotic thrombocytopenia (VITT) Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTEST HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.